Feb. 3 at 2:37 AM
$MIRA just dropped an 8-K and this one is very important
They’ve officially started dosing the FINAL cohort of their Phase 1 MAD trial for Ketamir-2.
50 healthy volunteers already dosed
Only 6 subjects left with Phase 1 expected to wrap by end of Q1 2026, this is huge… they wouldn’t announce this if MAD wasn’t producing successful results.
Phase 2a (CIPN) planned for Q2 2026, pending FDA feedback, ***Intend to pursue FDA Fast Track (CIPN has no approved treatments)***, Phase 1 data will be presented at AACR in April 2026 with Partnering discussions planned at BIO Summit in March
On top of all this:
SKNY-1 (oral wight loss and nicotine addiction) still advancing all while MIRA-55 inflammatory pain program is progressing toward IND…
This is a
$10 stock that’s currently going for a
$1 at this moment in time. Congrats to all who are holding. Tomorrow may be a rocket show, hold through the hype and fomo. It’s just the beginning.
